Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis.
Vasseur A, Cabel L, Hego C, Takka W, Trabelsi Grati O, Renouf B, Lerebours F, Loirat D, Brain E, Cottu P, Sablin MP, Pierga JY, Callens C, Renault S, Bidard FC.
Vasseur A, et al.
Oncogene. 2024 Apr;43(16):1214-1222. doi: 10.1038/s41388-024-02986-6. Epub 2024 Feb 27.
Oncogene. 2024.
PMID: 38413796
Free PMC article.